For Colon Cancer That No Longer Responds to Treatment, A New Drug Combination Offers Hope
April 25, 2025
April 25, 2025
DUARTE, California, April 25 -- City of Hope issued the following news release:
* * *
For Colon Cancer That No Longer Responds to Treatment, A New Drug Combination Offers Hope
Patients in a Phase 3 clinical trial who received sotorasib and panitumumab lived longer, suggesting the combination therapy could become the new standard of care.
LOS ANGELES -- A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic col . . .
* * *
For Colon Cancer That No Longer Responds to Treatment, A New Drug Combination Offers Hope
Patients in a Phase 3 clinical trial who received sotorasib and panitumumab lived longer, suggesting the combination therapy could become the new standard of care.
LOS ANGELES -- A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic col . . .